A Small Amount of Dietary Carbohydrate Can Promote the HFD-Induced Insulin Resistance to a Maximal Level by Mei, Shuang et al.
A Small Amount of Dietary Carbohydrate Can Promote
the HFD-Induced Insulin Resistance to a Maximal Level
Shuang Mei1., Xuefeng Yang2.¤a, Huailan Guo2¤b, Haihua Gu1, Longying Zha1,3, Junwei Cai4,
Xuefeng Li4, Zhenqi Liu5, Brian J. Bennett6, Ling He7*, Wenhong Cao1,4,8*
1 Nutrition Research Institute at Kannapolis, Department of Nutrition, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill,
North Carolina, United States of America, 2 Department of Nutrition, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America,
3 Department of Nutrition and Food Hygiene, South Medical University, Guangzhou, China, 4 Department of Medicine, Taihe Hospital, Hubei University of Medicine,
Shiyan, Hubei, China, 5 Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, United States of America, 6 Department of Human Genetics,
The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, 7 Department of Pediatrics, Johns Hopkins University School of
Medicine, Baltimore, Maryland, United States of America, 8 Department of Medicine (Endocrinology and Metabolism), Duke University School of Medicine, Durham, North
Carolina, United States of America
Abstract
Both dietary fat and carbohydrates (Carbs) may play important roles in the development of insulin resistance. The main goal
of this study was to further define the roles for fat and dietary carbs in insulin resistance. C57BL/6 mice were fed normal
chow diet (CD) or HFD containing 0.1–25.5% carbs for 5 weeks, followed by evaluations of calorie consumption, body
weight and fat gains, insulin sensitivity, intratissue insulin signaling, ectopic fat, and oxidative stress in liver and skeletal
muscle. The role of hepatic gluconeogenesis in the HFD-induced insulin resistance was determined in mice. The role of fat in
insulin resistance was also examined in cultured cells. HFD with little carbs (0.1%) induced severe insulin resistance. Addition
of 5% carbs to HFD dramatically elevated insulin resistance and 10% carbs in HFD was sufficient to induce a maximal level of
insulin resistance. HFD with little carbs induced ectopic fat accumulation and oxidative stress in liver and skeletal muscle
and addition of carbs to HFD dramatically enhanced ectopic fat and oxidative stress. HFD increased hepatic expression of
key gluconeogenic genes and the increase was most dramatic by HFD with little carbs, and inhibition of hepatic
gluconeogenesis prevented the HFD-induced insulin resistance. In cultured cells, development of insulin resistance induced
by a pathological level of insulin was prevented in the absence of fat. Together, fat is essential for development of insulin
resistance and dietary carb is not necessary for HFD-induced insulin resistance due to the presence of hepatic
gluconeogenesis but a very small amount of it can promote HFD-induced insulin resistance to a maximal level.
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Introduction
Obesity is closely associated with insulin resistance, which is a
necessary precursor and component of type 2 diabetes mellitus
(T2DM). That means that insulin resistance is also an essential
precursor of many major health problems associated with T2DM.
These problems include cardiocerebrovascular disorders, non-
alcoholic fatty liver, dementia, asthma, some cancers, and aging
[1–9]. In order to prevent all these major health problems, it is
imperative to fully understand how insulin resistance is caused by
different dietary components.
High fat diet (HFD, .37% fat in the diet) is associated with
insulin resistance in humans [10] and can consistently induce
obesity and insulin resistance in animal models [11–15]. There-
fore, fat has been generally blamed for the pandemic development
of T2DM. However, some studies have shown that fat-rich diets
can actually protect against insulin resistance and T2DM [16] and
the fat-rich Atkins diet and other diets are very popular among
many people. That means the jury is still out there about the exact
role of dietary fat in the development of insulin resistance and
T2DM. Similarly, the role of dietary carbohydrates (carbs) has not
been fully established or defined. Some studies have shown that
carb-rich diets promote development of insulin resistance and
T2DM [17,18] while others have shown that high-carb diet is
protective against insulin resistance and T2DM compared to HFD
[19], and low-carb diet is not necessarily protective against insulin
resistance and diabetes [20,21]. These conflicting results demon-
strate the complexity and difficulty in defining the role of each
dietary component in insulin resistance and T2DM. In order to
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accurately address the roles of dietary fat and carbs in insulin
resistance and T2DM, several key questions must be answered.
First, are dietary carbs necessary for the HFD-induced insulin
resistance? Second, how much carb is too much or sufficient to
promote the HFD-induced insulin resistance? Third, is fat essential
for insulin resistance? In this study, we addressed these questions
and the associated mechanisms.
Materials and Methods
Antibodies against phosphorylated Akt, total Akt, or b-actin
were from Sigma (St. Louis, MO). Antibodies against IRS-1Ser636,
UCP-1 were from Abcam (Cambridge, MA). Mouse IgG, and
rabbit IgG were obtained from Santa Cruz Biotechnology Inc.
(Santa Cruz, CA). RNeasy Mini Kit was from Qiagen (Valencia,
CA). GSH/GSSG ratio measuring kit was from OxisReaserch
(UK). MDA and MnSOD activity assay kits were from Cell
Biolabs (USA). Other materials were all obtained commercially
and are of analytical quality.
Animal experiments
C57BL/6 (B6) mice (male, 6–9 week old) were fed the standard
Prolab RMH 3000 chow diet (CD, 65.1% calories from carb,
23.1% calories from proteins, and 11.8% calories from fat) ad
libitum or high fat diet (HFD, 58%) plus 0.1%, 5%, 10%, or
25.5% carbohydrates (Carbs, maltodextrin) for 5 weeks and kept
at 12 h light and 12 h dark cycles as described [13]. The total
calorie densities of HFD with different amount of carb were the
same by adjusting the amount of proteins (casein) in the diets. All
HFD were from Research Diets (Cat#: D11101101, D11101102,
D11101103, and D12331). After an 8 h-fast at the end of every
week, blood glucose, body weight, food intake and water intake
were measured weekly. Some mice on HFD + 0.1% carb were
treated with adenoviral shRNA against p300 (109 pfu/mouse) or
the control shRNA at the beginning of week 5 as detailed
previously [22]. After an 8 h-fasting at the end of the 5th week,
insulin tolerance test (ITT) were performed by injecting human
insulin (0.75 U/kg body weight), followed by measurements of
blood glucose (0 min, 30 min, 60 min, 90 min, and 120 min) with
a glucosemeter. Blood samples were also collected. Sera were
obtained after centrifugation at 30006g for 10 min and stored at
280uC. Serum triglyceride (TG) and free fatty acids (FFA) were
measured with kits from Cayman Chemical (Cat No: 10010303
and 700310). Serum cholesterols were measured with Amplex red
cholesterol assay kit. Serum endogenous insulin was detected with
ELISA kits from Millipore (Cat No: EZRMI-13K and EZRMGH-
45K). Assays were performed according to the manuals from the
manufacturers. Tissues from liver and gastrocnemius were
obtained after animals were dead and stored at 280uC. All
animal studies were approved by the institutional animal care and
use committee of The University of North Carolina at Chapel Hill
and fully complied with the guidance from the National Institutes
of Health.
Measurement of food consumption
Food consumption was measured by subtracting the amount of
the food left and the initial amount of the food supplied. Energy
intakes were calculated on the basis of 3.81 kcal/g for the CD (Lab
Diet, Richmond, IN, USA) and 5.56 kcal/g for HFD groups.
Calories/BW (g)/day in chow diet group = (food supplied-food
left)*3.81/body weight/7 days. Calories/BW (g)/day in HFD
groups = (food supplied-food left)*5.56/body weight/7 days.
Measurements of lipids in tissues and plasma insulin
Triglyceride contents (TG) in liver and muscle were measured
with kits from Cayman Chemical (Cat No: 10010303) [14].
Endogenous plasma insulin level was quantified with an ELISA kit
from Millipore (Cat No: EZRMI-13K and EZRMGH-45K).
Assays were performed according to manuals from the manufac-
turers.
Immunoblotting
Thirty micrograms of total tissue proteins were denatured at
95uC for 5 min in loading buffer (60 mM Tris, 2.5% SDS, 10%
glycerol, 5% beta-mercaptoethanol, 0.01% bromphenol-blue)
and subjected to 10% SDS-PAGE. Proteins were transferred to
PVDF membranes and blocked with TBS buffer containing
0.05% Tween 20 (TBS-T) and 5% nonfat milk for 1 h. After
washing in TBS-T, membranes were probed with specific 1st
antibodies against target proteins (rabbit) or b-actin (mouse)
(1:1000) overnight at 4uC. Membranes were then washed with
TBS-T and incubated with polyclonal secondary goat anti-rabbit
or rabbit anti-mouse antibodies (1:5000; Santa Cruz Biotechnol-
ogy) for 1 h at room temperature. After three washes with TBS-
T, membranes were treated with ECF substrates, according to
the manufacturer’s protocol (Thermo Scientific). Fluorescent
bands were visualized and then quantified by densitometry
analysis using ImageQuant version 5.2 software from GE
Healthcare.
RNA extraction and real-time PCR
Total RNAs were extracted from tissues with an RNeasy Mini
Kit (Qiagen), and reverse-transcribed into cDNAs, which were
quantified by TaqMan Real-time PCR with probes and primers
were Srebp1(NM_011480.3): GGTTTTGAACGAC ATCGA-
AGA (forward) and CGGGAAGTCAC TGTCTT GGT (re-
verse). Srebp2/NM_033218.1: ACCTAGACCTCGCCAAAG
GT (forward) and GCACGGATAAGCAGGTT TGT (reverse).
Fas/NM_007988.3: CCAAATCCAACATGGGACA (forward)
and TGCTCCAGGGATAACAGCA (reverse). Results were
normalized to levels of M36B4.
Measurement of peroxidized lipids
Levels of peroxidized lipids in liver and muscle were indirectly
determined by measuring levels of malondialdehyde (MDA), a
byproduct of lipid peroxidation with a commercialized kit
(Northwest Life Science Specialties, USA) [23]. The level of
MDA was determined by quantifying the absorbance at 532 nm
and presented as mM/mg proteins.
Measurement of MnSOD activity
MnSOD activity in liver and muscle was determined by
using a commercialized kit (Cayman Chemical Company)
following the manufacturer’s instructions. Briefly, xanthine
oxidase and hypoxanthine were used to generate superoxide
radicals that were then detected by tetrazolium salt and
quantified at 540 nm with a microplate analyzer (Cell Biolabs,
USA). One unit of SOD was defined as the amount of enzyme
required to inhibit the distmutation of the superoxide radical
by 50%.
Measurement of glutathione (GSH)/glutathione disulfide
(GSSG) ratio
Levels of GSH and GSSG in tissue lysates were determined
with a kit from OXIS International, Inc. (Foster City, CA) and
normalized to protein levels [24]. The GSH/GSSG ratio was
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calculated according to the instruction provided by the
manufacturer. In brief, measurements of GSH and GSSG
and calculation of the GSH/GSSG ratio were performed in
the following four steps: 1) determination of reaction rate by
time; 2) construction of calibration curves; 3) calculation of the
analyst concentrations; and 4) calculation of the GSH/GSSG
ratio: GSH/GSSG ratio = (GSH- 2GSSG)/GSSG).
Statistical analysis
Data were presented as mean 6 SD compared among different
groups by one way ANOVA with Scheffe’s post-hoc test. (San
Diego, CA). Differences at values of p,0.05 were considered
significant.
Results
Dietary carbohydrates (carbs) are not necessary for the
HFD-mediated body weight gain but can promote body
weight gain in a dose-dependent manner in mice on
HFD
It is established that high sucrose- high fat-diet can cause body
weight gain (obesity) while the regular chow diet that contains
65.1% calories from carbs does not [11,12]. However, it has not
been defined whether or not dietary carbs are necessary for HFD
induction of body weight gain and how much dietary carb is
sufficient to promote body weight gain in animals on HFD. The
answer for this question is important because many people are
currently practicing or promoting low carb diets or high fat
(Atkins) diets with mixed results [25–28]. To answer this question,
Figure 1. Dietary carbohydrates (carbs) are not necessary for the high fat diet (HFD)-mediated body weight gain but can promote
the HFD-mediated weight gain in a dose-dependent manner. C57BL/6 (B6) mice were fed the regular chow diet (CD) ad libitum or HFD plus
0.1%, 5%, 10% or 25.5% carbs for 5 weeks. (A–B) Food and calorie intakes were recorded weekly. The ratio of food calories over body weight daily was
calculated. *: P,0.05 CD vs. either HFD +5% carbs or HFD +10% carbs. **: P,0.01 vs. CD. ##: P,0.01 vs. HFD +0.1% carbs. $$: P,0.01 HFD +5% carbs
vs. HFD +0.1% or HFD +25.5% carbs. &: P,0.05 HFD +10% carbs vs. HFD +25.5% carbs. (C) Body weight was measured weekly. *: P,0.05 vs. CD. **:
P,0.01 vs. CD. #: P,0.05 vs. HFD +0.1% carbs. ##: P,0.01 vs. HFD +0.1% carbs. $: P,0.05 HFD +5% carbs vs. HFD +25.5% carbs. $$: P,0.01 HFD +
5% carbs vs. HFD +25.5% carbs. &: P,0.05 HFD +10% carbs vs. HFD +25.5% carbs. (D) Epididymis fat pads were collected and weighed. The ratio of
epididymis fat over body weight was calculated. Results represent mean 6 SD of 10 mice/group. **: P,0.01 vs. CD. ##: P,0.01 vs. HFD +0.1% carbs.
$$: P,0.01 vs. HFD +5% carbs. ++: P,0.01 vs. HFD +10% carbs.
doi:10.1371/journal.pone.0100875.g001
Dietary Carbohydrates Dramatically Promote Insulin Resistance
PLOS ONE | www.plosone.org 3 July 2014 | Volume 9 | Issue 7 | e100875
we fed B6 mice with the regular chow diet, HFD (58% fat) + 0.1%
carbs, HFD (58% fat) + 5% carbs, HFD (58% fat) + 10% carbs, or
HFD (58% fat) plus 25.5% carbs for 5 weeks. Different amounts of
proteins were added to achieve equal calories per gram of HFD.
Calorie intake and body weight were evaluated once a week. As
shown in Fig. 1A–B, mice on all HFD groups took less food and
fewer calories than the mice on chow diet. At the end of 5 weeks,
the decrease of calorie intake in mice on HFD was proportional to
the amount of dietary carbs. But, animals on HFD gained more
weight when the level of dietary carbs was increased (Fig. 1C).
Specifically, animals with HFD + 0.1% carbs did not have an
absolute gain in body weight compared to those on chow diet, but
did gain more body weight per unit of calorie intake considering
their lower calorie intake. Mice on HFD with 5% carbs caused
absolutely more body weight gain and the HFD with 10% carbs
caused equal amount of body weight gain as the HFD with 25.5%
carbs, which is the standard level in experimental Surwit HFD in
animals [11,12]. It should be noted that mice on CD and all HFD
groups had or tended to have reduced food intake and body
weight in week 2 for an unknown reason. To determine the body
composition, we measured the ratio between white fat (epididymis
fat) over body weight. As shown in Fig. 1D, the white fat
proportion was increased in mice on HFD with little (0.1%) dietary
carbs, but the increase was further enhanced by dietary carbs in a
dose-dependent manner. Serum levels of cholesterol, triglyceride
(TG), and free fatty acids (FFA) were increased in all groups of
HFD (data not shown) as usual. Together, these results show that
dietary carbs are not essential for the HFD-induced body fat gain
Figure 2. Dietary carb is not necessary for the HFD-induced insulin resistance but a small amount of it can induce a maximal level of
insulin resistance in mice on HFD. (A) Fasting blood glucose was measured once a week after an 8-hour fast. (B) Plasma level of insulin was
evaluated at the end of the 5-week experiment after an 8 hour fast. (C–D) Insulin tolerance test (ITT) was performed at the end of the 5-week
experiment after an 8 hour fast and the area under curve was calculated. Results represent mean 6 SD of 8 mice/group. *: P,0.05 vs. CD. **: P,0.01
vs. CD. #: P,0.05 vs. HFD +0.1% carbs. ##: P,0.01 vs. HFD +0.1% carbs. $$: P,0.01 vs. HFD +5% carbs. ++: P,0.01 vs. HFD +10% carbs.
doi:10.1371/journal.pone.0100875.g002
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but can enhance the HFD-induced body fat gain in a dose-
dependent manner, and a very small amount of carbs (10%) in the
HFD can cause the maximal level of body weight gain.
Dietary carbs are not necessary for HFD to induce insulin
resistance but can aggravate insulin resistance in a
dose-dependent manner
It has been shown that high fat and high carbohydrate diet can
consistently induce insulin resistance although its effect on
induction of obesity and diabetes may vary a lot in B6 mice
[11,29]. To determine the role of dietary carbs in the HFD-
induced insulin resistance, we evaluated insulin sensitivity in the
animals described above by measuring fasting levels of blood
glucose and insulin and performing ITT in B6 mice. As shown in
Fig. 2A, fasting blood glucose level was increased in mice of all
HFD groups including the HFD with little (0.1%) carbs starting
from week 1, and the increase was promoted by dietary carbs in a
dose-dependent manner. Similarly, fasting plasma insulin level was
also increased in mice of all HFD groups, and the increase reached
a maximal level when the carbs in the HFD reached 10%
(Fig. 2B). As shown in Fig. 2C–D, insulin tolerance was
significantly decreased in mice on HFD with little (0.1%) dietary
carbs, and addition of carbs to HFD worsened insulin tolerance in
a dose-dependent manner. Together, these results show that
dietary carbs are not essential for the HFD-induced insulin
resistance but can promote the HFD-induced insulin resistance
dramatically, and 10% calories from dietary carbs can promote
insulin resistance to a maximal level in mice on HFD.
HFD causes insulin resistance in liver and skeletal muscle
with or without dietary carb
To determine whether dietary carbs are necessary for HFD to
induce insulin resistance in metabolically active tissues, we
examined the levels of serine phosphorylation of IRS1 and
phosphorylation of Akt in liver and gastrocnemius. As shown in
Fig. 3, HFD elevated serine phosphorylation of IRS1 in both liver
and gastrocnemius and the elevation was not obviously influenced
by the amount of dietary carbs in HFD. Similarly, Akt
phosphorylation induced by acute insulin challenge was blunted
by HFD with or without dietary carbs (Fig. 3). It is noteworthy
that mTOR activation was not influenced by the diets (Fig. 3A–
B). Together, these results indicate that HFD can induce insulin
resistance in metabolically active tissues with or without dietary
carbs and evaluation of intra-tissue insulin signaling components
can only tell whether or not insulin resistance is present but cannot
tell the exact extent of insulin resistance like ITT.
Figure 3. Dietary carb is not necessary for the HFD-induced insulin resistance. At the end of the 5-week experiment, animals were fasted
for 8 h. Liver (A) and skeletal muscle samples (B) were collected promptly after animals were sacrificed. Levels of total and phosphorylated IRS1, total
and phosphorylated Akt, total and phosphorylated mTOR, and b-actin were detected with immunoblotting. The level of each target protein was
quantified and normalized to control. The average of 3 mice was set at 1. Results were presented as mean 6 SD of 6 animals/group for Akt and 3
animals for IRS1. *: P,0.05 vs. no acute insulin treatment in control. **: P,0.01 vs. no acute insulin treatment in control.
doi:10.1371/journal.pone.0100875.g003
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Fatty acid/fat is necessary for the development of insulin
resistance induced by the chronic exposure to a
pathological level of insulin
As described above, all animals on HFD with or without dietary
carbohydrates developed insulin resistance while the animals on
chow diet that is a typical high carb (65.1%) and low fat diet
(11.8%) did not have insulin resistance. Surwit et al has previously
shown that mice on sucrose diet without fat does not intake excess
calories and their plasma levels of glucose and insulin are not
affected [30]. We and others have previously shown that insulin
plays an essential role in the HFD-induced insulin resistance
[13,14,31]. We asked how important fat was in the development of
insulin resistance induced by the chronic exposure to a patholog-
ical level of insulin (hyperinsulinemia) by depriving cells of
exogenous (no sera was added) and endogenous fatty acids (by
inhibition of fatty acid synthesis). As shown in Fig. 4A, in the
absence of chronic exposure to insulin, the acute insulin treatment
induced robust Akt phosphorylation in the presence or absence of
fatty acid synthesis inhibitor TOFA in hepatocytes. Note: the effect
of TOFA on fat synthesis should be minimal in such a short time
(15 min) as predicted. In contrast, in the presence of chronic
exposure to a pathological level of insulin, the acute insulin
treatment induced moderate Akt phosphorylation in the absence
of TOFA but stimulated robust Akt phosphorylation in the
presence of TOFA (Fig. 4A). TOFA alone did not influence Akt
phosphorylation (Fig. 4A). Similar results were observed in
cultured myocytes (Fig. 4B). Together, these results demonstrate
that fatty acid/fat is essential for the development of insulin
resistance induced by the chronic exposure to a pathological level
of insulin.
HFD with or without dietary carbs for 5 weeks induces
ectopic fat accumulation
We and many others have previously shown that HFD induces
ectopic fat accumulation [13,14], but the contribution of dietary
carbohydrates in this process remains unestablished. To address
this issue, ectopic accumulation of triglyceride (TG) in liver and
gastrocnemius was examined. As shown in Fig. 5A–B, TG
content was increased in liver and tended to increase in
gastrocnemius of all HFD groups, but the increasing trend in
gastrocnemius did not reach statistical significance. Expression of
fatty acid synthase (Fas) in liver was increased even in mice on
HFD with little carbohydrates and addition of carbohydrate (5–
25.5%) boosted the increase although expressions of SREBP-1c
and SREBP-2 increased only in mice on HFD with a high level of
dietary carbohydrates (10% and 25.5%) (Fig. 5C–E). In skeletal
muscle gastrocnemius, expression of Srebp-1c was increased in all
groups of HFD similarly with or without carbohydrates while
expressions of Srebp-2 and Fas were significantly increased only in
mice on HFD with 10% or 26% carbs (Fig. 5F–H). Together
these results show that HFD stimulates fat accumulation in liver
and addition of dietary carbohydrates does not influence the level
of HFD-induced ectopic fat accumulation although dietary
carbohydrates seem to influence the lipogenic program in both
liver and skeletal muscle.
Dietary carbs are not necessary for HFD to induce
oxidative stress
To further investigate the mechanisms of HFD-induced insulin
resistance, oxidative stress level was examined in several different
ways. As shown in Fig. 6A–B, GSH/GSSG ratio was decreased in
liver by HFD with little carb and the decrease was much more
dramatic when 5%, 10%, or 25.5% carbs were present in the
Figure 4. Fatty acid is essential for the development of insulin resistance induced by chronic exposure to insulin. Hep1c1c7 (A) and
differentiated C1C12 (B) cells were pretreated with TOFA (30.8 mM) for 50 min in media containing 25 mM glucose before the incubation with insulin
(1 nM, chronic insulin treatment) as noted in the continuous presence or absence of TOFA for another 12 h. After an extensive washing with warm
PBS, cells were exposed to insulin (5 nM) for 15 min (acute insulin treatment) as noted, followed by evaluations of phosphorylated and total target
proteins by using immunoblotting and quantification. No sera were added to the media throughout the whole experiment. Results represent mean
6 SE of 3 independent experiments. *: P,0.05 vs. no acute insulin treatment. **: P,0.01 vs. no acute insulin treatment.
doi:10.1371/journal.pone.0100875.g004
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HFD although the dose-dependent manner was not shown. In
gastrocnemius, the GSH/GSSG ratio was actually elevated when
HFD contained little (0.1%) carb, but decreased when the HFD
contained 10% 0r 25.5% carbs. The level of MnSOD activity was
increased in liver of mice on HFD that contained little carb (0.1%)
but more significantly when the HFD contained 5%, 10%, or
25.5% carbs with no dose dependence (Fig. 6C). The activity of
MnSOD was reduced in gastrocnemius of mice on HFD with
0.1%, 10%, or 25.5% carbs (Fig. 6D). The level of oxidized lipids
(MDA) was elevated in liver of mice on all HFD groups without a
carbohydrate dose-dependency (Fig. 6E). The level of MDA did
not increase in gastrocnemius of mice on HFD that contained little
(0.1%) carb, but did increase when HFD contained 5%, 10%, or
25.5% carbs (Fig. 6F). Together, these results show that HFD
with little carb for 5 weeks caused oxidative stress in liver but not
in skeletal muscle, but the HFD with 5% or more carbs caused
oxidative stress in both liver and skeletal muscle.
Due to presence of hepatic gluconeogenesis, dietary
carb was not necessary for HFD induction of insulin
resistance
To further investigate the mechanisms of insulin resistance
induced by HFD, we examined expression of key gluconeogenic
genes. As shown in Fig. 7A, expressions of both PEPCK and G-6-
Pase were increased by HFD, and the increase in PEPCK was
most significant in animals on HFD that contained little (0.1%)
carb. To determine the contribution of gluconeogenesis to the
HFD-induced insulin resistance, hepatic gluconeogenesis was
reduced by knocking down the p300 gene as previously described
[22]. As shown in Fig. 7B, HFD with little dietary carb induced
Figure 5. Dietary carb is not necessary for the HFD-induced ectopic fat accumulation in liver and skeletal muscle. At the end of the 5-
week experiment, animals were fasted for 8 h and liver and skeletal muscle samples were collected. Content of triglyceride (TG) in liver (A) and (B)
gastrocnemius were quantified. The mRNA levels of key lipogenic genes (Srebp-1c, Srebp-2, and fatty acid synthase (Fas)) in liver (C–E) and
gastrocnemius (F–H) were quantified by using Real Time RT/PCR. Results represent mean 6 SD of 4 mice per group. *: P,0.05 vs. CD. #: P,0.05 vs.
HFD +0.1% carbs. $: P,0.05 vs. HFD +5% carbs. +: P,0.05 vs. HFD +10% carbs.
doi:10.1371/journal.pone.0100875.g005
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Figure 6. Dietary carb is not necessary for the HFD-induced oxidative stress. Levels of GSH/GSSG ratio, MnSOD activity, malondialdehyde
(MDA) in liver (A, C, E) and gastrocnemius (B, D, F) of the mice described in Fig. 1 were measured and normalized to protein levels of the same
samples as detailed in ‘‘Methods and Materials’’. Results represent results of mean 6 SD of 10 animals per group. *: P,0.05 vs. CD. **: P,0.01 vs. CD.
#: P,0.05 vs. HFD +0.1% carbs. ##: P,0.01 vs. HFD +0.1% carbs. $$: P,0.01 vs. HFD +5% carbs.
doi:10.1371/journal.pone.0100875.g006
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insulin resistance, and this induction was totally prevented by
administration of adenoviral shRNA against p300 but not by the
control shRNA. These results demonstrate that dietary carb is not
necessary for HFD induction of insulin resistance due to presence
of hepatic gluconeogenesis.
Discussion
In investigating the effect of dietary composition on the
development of insulin resistance in mice in this study, we made
several novel findings.
Figure 7. Inhibition of hepatic gluconeogenesis prevented the HFD-induced insulin resistance. (A) Levels of key hepatic gluconeogenic
genes (PEPCK and glucose-6-phosphatase (G6P) were measured by using RT-PCR as detailed in ‘‘Methods and Materials’’. Results represent mean 6
SD of 4 mice per group. *: P,0.05 vs. CD. #: P,0.05 vs. HFD +0.1% carbs. (B) B6 mice were fed either the regular chow diet (CD) ad libitum or HFD
plus 0.1% carbs for 5 weeks. Some mice were treated with adenoviral shRNA against p300 (109 pfu/mouse) or the control shRNA at the beginning of
week 5. After an 8 h fast, IIT was performed. Protein levels of p300 in liver were verified by using immunoblotting. Results represent mean 6 SD of 5
mice per group. *: P,0.05 vs. CD. #: P,0.05 vs. HFD + shRNAp300 or CD.
doi:10.1371/journal.pone.0100875.g007
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First, dietary carb is not required for the HFD-induced weight
gain. It is known that B6 mice on HFD intake more calories than
the control mice on chow diet and leads to increased body weight
gain [11,12]. In addition to the excess ingestion of calories,
decreased thermogenesis is another contributor to the increased
body weight gain [32]. Furthermore, it has been previously shown
that HFD can promote weight gain by increasing feed efficiency
[30]. In this study, mice on HFD with any amount of carb (0.1%–
25.5%) ingested fewer calories compared to the controls on chow
diet (Fig. 1A), but mice on HFD of all groups gained more body
weight than controls relatively or absolutely; and the gain is
proportional to the amount of carbs in the diet (Fig. 1C). Since
the lipogenic program, fat accumulation, and the ratio of white
fat/body weight (Fig. 1D and 5) were all increased in animals on
HFD of all groups, the increased lipogenesis is likely the main
contributor to the increased body weight gain in mice of HFD.
Besides, the thermogenesis program was decreased because
expression of both UCP1 and PGC-1a was reduced in brown
fat of mice on HFD of all groups (data not shown). The inhibition
of thermogenic program was likely due to hyperinsulinemia in
these animals because it has previously been shown that inhibition
of insulin secretion with diazoxide prevented the HFD-induced
decrease in the expression of b3-adrenergic receptor, which is a
potent stimulator of PGC-1a and UCP1 expression in brown fat
[33]. Similarly, HFD decreased expression of UCP 2 and UCP3 in
skeletal muscle (data not shown). Thus, animals do not need to
take more calories to gain more body weight when they are on
HFD.
Second, dietary carb is not required for the HFD-induced
insulin resistance because of the presence of hepatic glucose
production via gluconeogenesis. Many studies have shown that
high-carb diets are associated with insulin resistance and T2DM
[17]. It has been well conceived that dietary carbs can increase
insulin secretion, which subsequently stimulate lipogenesis and
then cause insulin resistance [17,18]. However, it is currently
unestablished whether or not dietary carb is necessary for the diet-
induced insulin resistance. Results from this study show that mice
on HFD containing little carb (0.1%) developed severe insulin
resistance (Fig. 2). How did that happen? To replace the carb in
HFD, ,42% calories of the HFD used in this study was from
proteins. Protein-rich diets have been shown to induce insulin
resistance probably through activation of mTOR and S6K
signaling pathway [34,35]. However, activity of mTOR in animals
of this study was not altered (Fig. 3). Therefore, the mTOR-S6K
signaling pathway was not the likely mechanism of insulin
resistance of this study. It is noteworthy that hepatic gluconeo-
genesis program was significantly increased in mice on HFD with
little carbs and inhibition of hepatic gluconeogenesis by knocking
down p300 completely prevented the HFD-induced insulin
resistance (Fig. 7). In other words, glucose from gluconeogenesis
is sufficient to stimulate sufficient secretion of insulin, which is
necessary for the fat- or glucose-induced insulin resistance [14,24].
Third, a very small amount of dietary carb is sufficient to
promote the HFD-induced insulin resistance to a maximal level.
Although it is known that dietary carbs play a key role in the
development of insulin resistance and T2DM, it is unknown how
much dietary carb is too much or sufficient to enhance insulin
resistance in humans or animals on HFD. Our results show that a
very small amount of dietary carb (5%) in HFD can worsen insulin
resistance dramatically, and 10% carb in HFD can cause the
maximal level of insulin resistance (Fig. 2). With the increase of
carbohydrates in the diet there was a decrease in the level of
dietary proteins, it was possible although not likely that the
increased insulin resistance in mice on HFD with higher levels of
carbohydrates might be caused by the decreased protein level in
the HFD. However, considering the unaltered mTOR activation
level (Fig. 3B) and prevention of the HFD-induced insulin
resistance by reducing gluconeogenesis (Fig. 7), we believe that
the effect of changes in protein level is not likely the primary
contributor to the changes in insulin sensitivity in this study. In any
way, our results may help explain why all kinds of diets are out
there with conflicting results. Some studies show low carb diets
protects against insulin resistance and T2DM while others show
the opposite [17,20,21]. That is likely due to the different amounts
of carb in the so-called low-carb diets. The amount of carbs in
some of those assumed low carb might contain enough carbs to
stimulate insulin secretion and induce insulin resistance while that
of other low-carb diets is not sufficient to enhance insulin secretion
and induce insulin resistance.
Fourth, the lipogenic program (SRBEPs and Fas) was stimulated
in all HFD groups with or without dietary carbs and was enhanced
by dietary carbs in a dose-dependent manner. The lipogenic
program is predominantly stimulated by insulin through the
central regulator SREBP-1c and its down-stream effector Fas [36].
Therefore, it is easy to appreciate the dose-dependent increase of
lipogenic program by dietary carbs in HFD. However, the
increased lipogenic program and ectopic fat accumulation of
animals on HFD with little carb seems puzzling. But considering
the elevated gluconeogenic program and increased fasting insulin
level in those mice, it should be understandable. Typically, HFD-
induced ectopic fat accumulation occurs in both liver and skeletal
muscle as previously shown [13,14]. In this study, fat accumulation
in liver was obvious but did not reach a statistical significance in
skeletal muscle for an unclear reason. Mitochondria-derived
oxidative stress plays a critical role in the development of insulin
resistance induced by fat or cytokines [37–40]. We and others
have previously shown that chronic exposure to excess insulin can
induce mitochondria-derived oxidative stress through long chain-
acyl CoAs or/and cholesterol [14,41]. Since animals on HFD with
or without dietary carbs all had hyperinsulinemia (Fig. 2) and
hyperlipidemia (data not shown), it is evident that they would all
have oxidative stress (Fig. 6).
In summary, our results show that dietary carb is not necessary
for the HFD-induced insulin resistance because of the presence of
hepatic gluconeogenesis but a very small amount of it (5%) can
dramatically worsen the HFD-induced insulin resistance and 10%
carb in the HFD can induce a maximal level of insulin resistance.
Fat is essential for development of insulin resistance.
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